Announcement under Regulation 30 (LODR)-Press Release / Media Release

Registered Office: 103, Akruti Arcade, Opposite A H Wadia High School, Near Azad Nagar Metro Station, Andheri (West), Mumbai –400058. Tel: 022 61437991 | Email: info@laxmidentallimited.com; co.sec@laxmidentallimited.com | Website: www.laxmidentallimited.com CIN No: L51507MH2004PLC147394 | GST No: 27AABCL0001A1ZL Date: November 03, 2026 Listing Department Listing & Compliance Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, 5th Floor Dalal Street, Mumbai – 400001 Plot No. C/1, “G” Block BSE Scrip Code: 544339 Bandra-Kurla Complex Bandra (E), Mumbai – 400 051 Symbol: LAXMIDENTL Re: LAXMI DENTAL LIMITED - ISIN: INE0WO601020 Dear Sir(s)/Madam(s), Sub: Intimation of Press Release on Unaudited Consolidated Financial Results for the quarter and half year ended September 30, 2026 of Laxmi Dental Limited (“the Company”). Pursuant to the provisions of Regulation 30 read with Para A Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from time to time, we enclose herewith a press release, being issued by the Company on the Unaudited Consolidated Financial Results of the Company for quarter and half year ended on September 30, 2026. The same shall also be uploaded on website of the Company at https://www.laxmidentallimited.com/for- investors Kindly take the above on record. For Laxmi Dental Limited -------------------------------------------------- Suman Saha Company Secretary and Compliance Officer ICSI Membership Number: A33035 Encl.: As above. Earnings Release Laxmi Dental Limited Q2 & H1 FY27 Consolidated Results Tuesday, 3rd November 2026, Mumbai – Laxmi Dental Limited (BSE - 544339, NSE – LAXMIDENTL), a leading integrated dental products company, announced its unaudited financial results for the quarter and half year ended 30th September 2026. Consolidated Result Highlights Consolidated P&L (INR mn) Q2FY27 Q2FY26 YoY Q1FY27 QoQ H1FY27 H1FY26 YoY Revenue from operations1 795.2 722.7 10.0% 747.0 6.5% 1,542.2 1,378.6 11.9% EBITDA 152.7 110.2 38.5% 143.6 6.3% 296.3 229.3 29.2% EBITDA Margin 19.2% 15.3% 19.2% 19.2% 16.6% PAT after share of profit/loss 100.4 85.3 17.6% 103.2 -2.7% 203.5 168.6 20.7% from JVs PAT Margin (after share of JVs) 12.6% 11.8% 13.8% 13.2% 12.2% Adjusted EBITDA2 160.1 136.7 17.1% 159.6 0.3% 319.6 284.5 12.4% Notes: 1. As per Ind AS norms revenue does not include revenue from Kids-e-Dental and IDBG AI Dent as they are jointly controlled entities. 2. Adjusted EBITDA is calculated as Reported EBITDA + ESOP expenses (non-cash in nature) + 60% of Kids-e-Dental PAT + 49% of IDBG AI Dent PAT. Q2 FY27 Performance Highlights • Highest-ever quarterly revenue and EBITDA driven by core dental products. • Gross margins for dental laboratory and aligner solutions were stable at a healthy level. Overall, the gross margins improved to 76.9%, due to the change in product mix. • Scanner sales contribution for the quarter was low at INR 3.5 crore as against INR 8.9 crore in the same period last year. • Increase in employee expenses is on account of annual increments and addition of people in domestic sales, operations and US business. • ESOP expenses, which are non-cash in nature, stood at INR 2.1 Mn in Q2FY27, compared to INR 16.8 Mn in Q2FY26. The reduction includes approx. INR 6 Mn reversal of ESOP expenses for employees who have left the organisation or surrendered their options, as approved by the Board. • Other expenses were lower sequentially and grew year-on-year due to higher business promotion, freight cost and spend on AI-led automation. • EBITDA margin grew on a YoY basis and sustained sequentially. • Going forward, as a part of our digitalisation strategy, we plan to deploy scanners on a subscription model, reducing upfront adoption costs, making the solution more affordable for dentists as well as increasing stickiness and driving incremental business for Laxmi Dental. Earnings Release Management Commentary Commenting on the performance Rajesh Vrajlal Khakhar, Chairperson and Whole-time Director said, “We are delighted to report another strong quarter, building on the positive start we made to FY27. Q2FY27 reported a highest ever quarterly revenue of INR 79.5 crore, taking H1FY27 revenue to INR 154.2 crore. Growth was broad-based across our Dental Laboratory and Aligner Solutions businesses. EBITDA and PAT margins stood at 19.2% and 12.6%, respectively. Profitability remained healthy, supported by code dental product mix and continued operating discipline. This performance reflects our innovative strategies tailored to each region and business, alongside our continued focus on digitalisation and brand building. During the quarter, our shareholders approved changes in the IPO use of proceeds, allowing INR 48.1 crore of unutilised proceeds to be redeployed, including INR 26.9 crore towards land and building for a company-owned, integrated dental laboratory and aligner facility. This is expected to enhance efficiency, strengthen cost control and support scalability. The transition will be in a phased manner to ensure service continuity without any material impact. Looking at the bigger picture, India’s dental industry is at an early stage of a structural shift. A highly fragmented lab market is gradually organising, dentists are adopting digital workflows, and patients are increasingly choosing quality, aesthetics and trusted brands. Globally too, demand for customised restorations has been rising, and dentists are increasingly turning to companies like Laxmi Dental that deliver superior quality and faster turnaround time at a competitive cost. Over more than three decades, Laxmi Dental has built the trust, quality systems, brands and infrastructure needed to lead this transition. We believe the decade ahead holds great promise for dentistry in India and globally. We continue to build our capabilities to capture this opportunity responsibly and sustainably.” Commenting on the performance Sameer Kamlesh Merchant, Managing Director and CEO said, “During Q2FY27, the Company delivered a strong performance across segments. For the quarter, our dental laboratory business grew by 22.7% year-on-year with robust growth in international operations of 32.0% and healthy growth in domestic operations of 15.0%. Aligner Solutions also delivered a strong growth of 23.5% year-on-year, driven by both Bizdent and Vedia, with 27.7% and 19.1% year-on-year growth, respectively. Our paediatric business, Kids-e-Dental, also continued to scale well with a year-on-year growth of 16.7%. Scanner sales for the quarter remained muted due to inflated prices for high-end laptops. We continue to evaluate our scanner roadmap in line with the overall market situation. Our performance reflects the strength of long-standing relationships with dental partners in India and overseas, supported by consistent execution across our sales and operations teams. We continue to invest in AI-led automation to make our operations faster, more consistent and efficient as we grow. In the Indian market we remain focused on increasing our wallet share with existing dentists and adding new dental partners through our hub-and-spoke strategy and digitalisation. Internationally, the strengthened on- ground leadership in the US, our participation at the upcoming International Dental Show (IDS) and the India– EU Free Trade Agreement concluded earlier this year are all expected to support our global expansion. With continued progress in digitalisation, innovation, branding and network expansion, we remain well positioned to deliver sustainable and profitable growth in the years ahead.” Earnings Release About Laxmi Dental Limited Incorporated in 2004, Laxmi Dental Limited is an integrated dental products company offering a comprehensive portfolio of dental products. It is India’s only end-to-end integrated dental products company as of September 2024 [Showing first 8,000 characters — download PDF for full document]